5.4 Refill Exceptions & Emergency Dispensing

Refills — The Federal Baseline

Under 21 CFR § 1306.12, Schedule II prescriptions may not be refilled. A new, signed prescription (paper or electronic, compliant with 21 CFR Part 1311 EPCS) is required for each CII dispensing. The only federal refill-like exception is for a patient in a long-term care facility (LTCF) or terminally ill patient, where a pharmacist may dispense a compound containing a CII substance for direct administration to the patient by a practitioner — not for patient self-administration — on receipt of an original Rx or a facsimile or verbal order, with the original prescription retained.

For CIII–CV, 21 CFR § 1306.22 authorizes up to 5 refills within 6 months from the date of issue. After 6 months or 5 refills, the prescription is void and a new prescription is required. PA applies this federal floor and adds no broader state refill authority.

Emergency Dispensing of CIII–CV Without a Prescription

Under 21 CFR Part 1306 Subpart C (oral CIII–V prescriptions), a pharmacist may dispense a CIII, CIV, or CV controlled substance in an emergency without a written or electronic prescription if all of the following are true:

1. The drug is needed to maintain the patient's treatment regime or to support treatment of an acute condition.
2. The pharmacist contacts the prescriber and obtains a written, oral, or facsimile prescription within 7 days of the emergency dispensing.
3. The pharmacist records the date, patient, drug, quantity, prescriber, and the reason for the emergency in a separate emergency-dispensing log.
4. The quantity dispensed is limited to what is needed to cover the emergency — commonly a 72-hour supply, though the regulation technically authorizes the amount needed until the prescription can be received.

PA applies this federal rule. Failure of the prescriber to deliver the prescription within 7 days is reported to the Board and DEA. The dispensing cannot be repeated on the same authorization once the 7-day window closes.

Emergency Oral CII Prescriptions — The DEA Exception

DEA permits a CII prescription to be communicated orally (or by fax in limited cases) only in a true emergency, defined as a situation in which:

1. Immediate administration of the drug is necessary for the proper treatment of the patient.
2. No alternative (non-CII) treatment is adequate or appropriate.
3. It is not feasible for the prescriber to provide a written, signed prescription before dispensing.

The pharmacist must:

• Reduce the oral prescription to writing immediately, capturing all required elements.
• Note on the face of the prescription that it was received by emergency oral communication.
• If the prescriber does not deliver a written, signed prescription covering the emergency quantity within 7 days, the pharmacist must notify the DEA Diversion Field Office in writing within 7 days.
• No refills may be authorized under the emergency oral CII exception.

This exception is narrow. "The office is closed on Friday and the patient is traveling" is not a true emergency. True emergencies include acute severe pain after surgery when the prescriber cannot transmit an EPCS prescription before the pharmacy closes, or end-of-life pain escalation.

Refill-Too-Soon Edits and Overrides

Pharmacy management systems flag refills filled before ~75% of the days supply has elapsed. The MPJE tests whether the pharmacist may override the edit. Generally, the pharmacist may override only when:

• The prescriber authorizes an early refill in advance (e.g., patient traveling for an extended period).
• The patient has a documented loss, theft, or destruction of the medication (a police report may be required for CII–CV).
• A dose change requires a new quantity mid-cycle.

Each override requires documentation. For controlled substances, a PDMP query is appropriate when loss, theft, or repeated early refills are reported. For loss or theft of a controlled substance, the patient should be advised to file a police report; the pharmacist documents the report and the prescriber's authorization before dispensing a replacement.

Vacation and Lost-Medication Overrides

Vacation overrides are pharmacy-managed for non-controlled and, with prescriber authorization, for controlled substances. The pharmacist documents the travel dates and the prescriber's approval and overrides the refill-too-soon edit. For CII, because there are no refills, a vacation supply requires a new prescription; the prescriber may write for an increased quantity appropriate to the trip but the dispense is a single fill.

Lost-medication replacements for controlled substances require prescriber authorization and, for CII–CV, documentation of the loss (often a police report). The pharmacist should query the PDMP and consider whether the pattern suggests diversion.

Partial Fills of CII

The SUPPORT Act (2018) amended 21 CFR to allow partial fills of CII prescriptions:

• The patient (or caregiver) may request a partial fill.
• The remaining quantity may be filled at the same pharmacy within the prescription's validity period.
• A CII prescription is valid for 6 months from the date of issue federally (PA does not shorten this, but the prescription may be void earlier if the prescriber revokes it).
• Partial fills cannot exceed the total quantity originally prescribed.
• Each partial fill is logged; the pharmacy tracks the remaining quantity.

A CII prescription cannot be split across multiple pharmacies — partial fills must occur at the pharmacy that received the original prescription. The patient may not take a CII prescription to a second pharmacy to fill the remaining quantity.

PA Acute-Pain Opioid Limits and Emergency Context

PA's acute-pain opioid limits interact with emergency dispensing:

• Act 122 of 2016 (Safe Emergency Prescribing Act) — Effective January 1, 2017: in an ED, urgent care, or hospital observation setting, an opioid prescription is limited to a 7-day supply with no refills.
• Act 125 of 2016 — Effective February 4, 2017: opioid prescriptions for minors (under 18, emancipated minors excepted) are limited to 7 days with written parent/guardian consent, or a single 72-hour supply with an authorized adult's consent.
• Act 112 of 2019 — Effective November 27, 2019: prescribers must establish an opioid treatment agreement before issuing the first opioid prescription for chronic pain (not an acute-pain 7-day cap).
• Exceptions to the 7-day limits: cancer, palliative/hospice care, chronic pain (with Act 112 treatment agreement), major surgical procedures (documented).

The 72-hour emergency CIII–CV supply and the 72-hour minor opioid consent window are different rules — do not conflate them on the exam.

Summary of Emergency Scenarios

Common MPJE traps

• "I can dispense a 72-hour supply of any controlled substance, including CII, without a prescription in an emergency." — No. The 72-hour emergency rule applies to CIII–CV only; CII requires the emergency oral Rx procedure with 7-day written follow-up.
• "A partial CII fill can be completed at a different pharmacy." — No. Partial fills must occur at the same pharmacy that received the original prescription; cross-pharmacy completion is prohibited.
• "If the prescriber never sends the written CII emergency Rx, the pharmacist just documents it." — No. The pharmacist must notify DEA within 7 days in writing.
• "Vacation is a valid reason to override a CII refill." — CII has no refills to override; a new prescription is required.
• "PA's 7-day opioid limit applies to chronic pain." — No. Act 122's 7-day limit applies only to ED/urgent-care/observation prescribing; Act 125's 7-day limit applies to minors. Chronic pain is a documented exception, and chronic-pain opioid prescribing triggers Act 112 of 2019 treatment-agreement requirements instead. Cancer and palliative/hospice are also documented exceptions.